| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
55,220,000 |
| Market
Cap: |
552.20(K) |
| Last
Volume: |
36,921,266 |
Avg
Vol: |
36,821,389 |
| 52
Week Range: |
$0.03 - $2.83 |
|
| Level
I Sector: |
Consumer Discretionary |
| Level
II Sector: |
Retail |
| Level
III Sector: |
Drug Stores |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Rite Aid provides an array of whole being health products and services. Co. reports its business in two segments: Retail Pharmacy Segment, which provides a range of healthcare services, including administering immunizations against coronavirus, the flu, shingles and more, as well as Health Dialog, a provider of healthcare coaching and disease management services to health plans and employers; and Pharmacy Services Segment, which includes its pharmacy benefit management (PBM), Elixir, that provides a suite of PBM offerings including technology solutions, mail delivery services, specialty pharmacy, network and rebate administration, claims adjudication and pharmacy discount programs.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-21 |
2023-12-19 |
2023-06-20 |
2022-06-20 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  De Bruin Jerry Mark |
Executive VP - Pharmacy |
• – – |
2007-04-05 |
4 |
D |
$6.00 |
$17,178 |
D/D |
(2,863) |
144,907 |
|
- |
|
| Miller Robert Gerald |
Director |
– • – |
2006-12-27 |
4 |
S |
$5.52 |
$1,654,530 |
D/D |
(300,000) |
12,779 |
|
- |
|
| De Bruin Jerry Mark |
EVP - Pharmacy |
• – – |
2006-10-10 |
4 |
A |
$0.00 |
$0 |
D/D |
125,000 |
272,770 |
|
- |
|
| De Bruin Jerry Mark |
Executive VP - Pharmacy |
• – – |
2006-10-10 |
4 |
D |
$4.56 |
$77,160 |
D/D |
(16,921) |
147,770 |
|
- |
|
| Panzer Mark C |
Chief Marketing Officer |
• – – |
2006-09-22 |
4 |
D |
$4.63 |
$37,605 |
D/D |
(8,122) |
200,898 |
|
- |
|
| Mastrian James P |
Chief Operating Officer |
• – – |
2006-09-22 |
4 |
D |
$4.63 |
$78,344 |
D/D |
(16,921) |
500,505 |
|
- |
|
| Panzer Mark C |
Senior Executive VP & CMO |
• – – |
2006-06-24 |
4 |
D |
$4.18 |
$6,048 |
D/D |
(1,447) |
209,020 |
|
- |
|
| Panzer Mark C |
Senior Executive VP & CMO |
• – – |
2006-06-23 |
4 |
D |
$4.18 |
$5,948 |
D/D |
(1,423) |
210,467 |
|
- |
|
| De Bruin Jerry Mark |
Executive VP, Pharmacy |
• – – |
2006-06-23 |
4 |
D |
$4.18 |
$2,270 |
D/D |
(543) |
164,691 |
|
- |
|
| Twomey Kevin |
Executive VP & CFO |
• – – |
2006-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
5,942 |
82,418 |
|
- |
|
| Sari Robert |
Executive VP, General Counsel |
• – – |
2006-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
5,430 |
56,626 |
|
- |
|
| Sammons Mary F |
President & CEO |
• • – |
2006-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
24,434 |
1,003,604 |
|
- |
|
| Panzer Mark C |
Senior Executive VP & CMO |
• – – |
2006-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
9,969 |
211,890 |
|
- |
|
| Mastrian James P |
Senior Executive VP & COO |
• – – |
2006-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
12,624 |
520,652 |
|
- |
|
| Donley Douglas E |
SVP,Chief Accounting Officer |
• – – |
2006-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
2,977 |
28,381 |
|
- |
|
| De Bruin Jerry Mark |
Executive VP, Pharmacy |
• – – |
2006-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
5,243 |
165,234 |
|
- |
|
| Sari Robert |
Executive VP,General Counsel |
• – – |
2006-04-07 |
4 |
D |
$0.00 |
$0 |
D/D |
(376) |
51,196 |
|
- |
|
| Donley Douglas E |
Senior VP & CAO |
• – – |
2006-04-07 |
4 |
D |
$0.00 |
$0 |
D/D |
(242) |
25,404 |
|
- |
|
| De Bruin Jerry Mark |
Executive VP, Pharmacy |
• – – |
2006-04-07 |
4 |
D |
$0.00 |
$0 |
D/D |
(376) |
159,991 |
|
- |
|
| De Bruin Jerry Mark |
Executive VP - Pharmacy |
• – – |
2006-04-05 |
4 |
A |
$0.00 |
$0 |
D/D |
28,055 |
160,367 |
|
- |
|
| Sammons Mary F |
President & CEO |
• • – |
2006-04-05 |
4 |
A |
$0.00 |
$0 |
D/D |
199,501 |
979,170 |
|
- |
|
| Twomey Kevin |
Executive VP & CFO |
• – – |
2006-04-05 |
4 |
A |
$0.00 |
$0 |
D/D |
31,796 |
76,476 |
|
- |
|
| Sari Robert |
Executive VP & General Counsel |
• – – |
2006-04-05 |
4 |
A |
$0.00 |
$0 |
D/D |
28,055 |
51,572 |
|
- |
|
| Panzer Mark C |
Senior Executive VP-Marketing |
• – – |
2006-04-05 |
4 |
A |
$0.00 |
$0 |
D/D |
74,813 |
201,921 |
|
- |
|
| Mastrian James P |
Senior Executive VP and COO |
• – – |
2006-04-05 |
4 |
A |
$0.00 |
$0 |
D/D |
74,813 |
508,028 |
|
- |
|
818 Records found
|
|
Page 31 of 33 |
|
|
0.01 (50%) 
